Table 1.

Thyroid Cancer–Specific and Recurrence-Free Survival at 5, 10, and 20 Years Based on Historic Versus Contemporary Diagnosis of Follicular Carcinoma

Survival indicator	5 years	10 years	20 years
Thy-Ca-specific survival, historic FTC Dx	89.9%	83.5%	75.1%
Thy-Ca-specific survival, contemporary FTC Dx	77.0%	77.0%	33.7%
Thy-Ca-specific survival, contemporary FTC Dx, patients with STI or DM	55.6%	55.6%	14.8%
Recurrence-free survival, historic FTC Dx	90.3%	83.0%	83.0%
Recurrence-free survival, contemporary FTC Dx	69.2%	46.2%	46.2%

Lowest survivals indicated in bold italics.

Thy-Ca, thyroid cancer; FTC, follicular thyroid carcinoma; Dx, diagnosis; STI, soft tissue invasion; DM, distant metastasis.